Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Press Releases
Other News
Aug 18 2023
Redeye interviewed Øystein Rekdal about Lytix and his role as CEO
Read more...
Aug 14 2023
The positive interim Phase II data with LTX-315 from Verrica Pharmaceuticals Inc. (Lytix Biopharma’s licensing partner) stirs attention
Read more...
Aug 10 2023
Redeye initiates coverage of Lytix Biopharma
Read more...
May 30 2023
Lytix Biopharma’s innovative and unique solution emphasized in national clinical research report
Read more...
May 12 2023
Hear our CEO, Øystein Rekdal, explaining how our technology has the potential to solve the major challenge in current cancer therapy
Read more...